| Financial Year |
March 31 2023 |
| Monetary Funds |
507,503,922.62 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
335,437,266.34 |
| Advances to Suppliers |
160,461,743.52 |
| Other Receivables |
26,861,887.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
763,706,111.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
95,553,671.01 |
| Total Current Assets |
1,972,226,625.88 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
7,653,719.23 |
| Investment Properties |
-- |
| Fixed Assetes |
26,258,165.56 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,101,205.30 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,982,621.17 |
| Deferred Income Tax Assets |
221,956,888.07 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
288,958,963.94 |
| Total Assets |
2,261,185,589.82 |
| Short-Term Loans |
92,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
76,465,864.89 |
| Accounts Received In Advance |
30,849,261.16 |
| Employee Compensation Payable |
5,562,842.09 |
| Taxes Payable |
11,003,501.02 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
200,504,411.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,407,089.19 |
| Other Current Liabilities |
67,486,692.46 |
| Sub-Total of Current Liabilities |
712,214,298.32 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
40,164,937.29 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
40,164,937.29 |
| Total Liabilities |
752,379,235.61 |
| Paid-In Capital(Or Share Stock) |
980,980,473.00 |
| Capital Surplus |
1,130,729,240.12 |
| Surplus Reserve |
30,835,474.82 |
| LESS:Treasury Stock |
34,000,000.00 |
| Undistributed Profits |
-582,728,050.12 |
| Minority Stockholder's Interest |
-17,010,783.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,525,817,137.82 |
| Owner's Equity（Stockholder's Equity） |
1,508,806,354.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,261,185,589.82 |
